IRIS
MAGLIANI, Valter
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.217
AS - Asia 11.691
EU - Europa 8.582
SA - Sud America 2.094
AF - Africa 702
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 5
Totale 35.313
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.811
SG - Singapore 4.353
CN - Cina 3.567
VN - Vietnam 1.959
BR - Brasile 1.647
UA - Ucraina 1.492
DE - Germania 1.326
IE - Irlanda 1.310
FI - Finlandia 1.068
IT - Italia 960
SE - Svezia 892
HK - Hong Kong 833
ZA - Sudafrica 523
FR - Francia 403
NL - Olanda 402
CA - Canada 293
TR - Turchia 204
GB - Regno Unito 180
AR - Argentina 170
RU - Federazione Russa 154
BD - Bangladesh 150
AT - Austria 143
IN - India 113
EC - Ecuador 103
JP - Giappone 73
IQ - Iraq 71
MX - Messico 70
ID - Indonesia 54
ES - Italia 50
BE - Belgio 44
CO - Colombia 44
MA - Marocco 41
PL - Polonia 41
PY - Paraguay 37
PK - Pakistan 34
KE - Kenya 32
VE - Venezuela 32
PH - Filippine 31
EG - Egitto 27
CL - Cile 26
KR - Corea 25
UZ - Uzbekistan 24
JO - Giordania 22
TN - Tunisia 22
TW - Taiwan 22
TH - Thailandia 21
RO - Romania 20
SA - Arabia Saudita 20
EU - Europa 19
AZ - Azerbaigian 15
IL - Israele 15
KZ - Kazakistan 15
UY - Uruguay 15
AE - Emirati Arabi Uniti 13
CZ - Repubblica Ceca 13
LT - Lituania 13
NP - Nepal 13
ET - Etiopia 11
CI - Costa d'Avorio 10
BO - Bolivia 9
BG - Bulgaria 8
OM - Oman 8
PE - Perù 8
TT - Trinidad e Tobago 8
CH - Svizzera 7
AL - Albania 6
CR - Costa Rica 6
DZ - Algeria 6
HN - Honduras 6
HU - Ungheria 5
IR - Iran 5
LB - Libano 5
RS - Serbia 5
BA - Bosnia-Erzegovina 4
BB - Barbados 4
BY - Bielorussia 4
EE - Estonia 4
JM - Giamaica 4
NG - Nigeria 4
NI - Nicaragua 4
PS - Palestinian Territory 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
AO - Angola 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
GE - Georgia 3
HR - Croazia 3
LU - Lussemburgo 3
LV - Lettonia 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
XK - ???statistics.table.value.countryCode.XK??? 3
ZW - Zimbabwe 3
AM - Armenia 2
AU - Australia 2
BW - Botswana 2
GD - Grenada 2
GR - Grecia 2
Totale 35.270
Salva come PNG Salva come JPEG
Città #
Singapore 1.894
Jacksonville 1.542
Dublin 1.306
San Jose 1.259
Ashburn 1.062
Chandler 1.006
Beijing 960
Hong Kong 805
Dearborn 762
Ho Chi Minh City 627
Santa Clara 530
Boardman 503
Johannesburg 494
Nanjing 486
Hanoi 448
Dallas 409
Princeton 365
Lauterbourg 318
Ann Arbor 286
San Mateo 285
Munich 261
Toronto 214
Wilmington 207
New York 189
Parma 178
Helsinki 171
Kunming 171
Bremen 167
Shenyang 155
Hefei 154
Izmir 152
Los Angeles 147
Nanchang 139
Vienna 131
São Paulo 128
Hebei 118
Shanghai 117
Moscow 116
Des Moines 101
Jinan 95
Da Nang 83
Haiphong 81
Tianjin 72
Buffalo 71
Grafing 68
Jiaxing 63
Changsha 58
Guangzhou 58
Rio de Janeiro 57
Woodbridge 51
Seattle 50
Rome 49
Norwalk 47
Turku 47
Brussels 42
Council Bluffs 42
Fortaleza 42
Tokyo 42
Columbus 40
Brasília 38
Düsseldorf 37
Frankfurt am Main 36
Biên Hòa 35
Fremont 35
Warsaw 34
Zhengzhou 34
Hải Dương 32
Marseille 32
Quito 32
Bắc Ninh 31
Hangzhou 31
Guayaquil 30
Brooklyn 29
Houston 29
Milan 29
Baghdad 28
Orem 28
Nairobi 26
Atlanta 25
Can Tho 25
Chengdu 24
Salvador 24
Chennai 23
Montreal 23
Porto Alegre 23
Thái Bình 23
Belo Horizonte 22
The Dalles 22
Curitiba 21
Amman 20
Denver 20
Fuzhou 20
Tashkent 20
Campinas 19
Chicago 19
Nuremberg 19
Boston 18
Jakarta 18
Ningbo 18
San Francisco 18
Totale 20.591
Salva come PNG Salva come JPEG
Nome #
A transphyletic anti-infectious control strategy based on the killer phenomenon. 283
Anaflatoxin B1 as the Paradigm of a New Class of Vaccines Based on “Mycotoxoids” 247
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 245
Capitolo 5. Differenziamento reale e differenziamento temporaneo. 232
Novel activity of a synthetic decapeptide against Toxoplasma gondii Tachyzoites 221
Dissecting the structure-function relationship of a fungicidal peptide derived from the constant region of human immunoglobulins 215
Anti-infective antibody-derived peptides active against endogenous and exogenous fungi 203
In vitro and in vivo anti-Candida activity and structural analysis of killer peptide (KP)-derivatives 201
Antibodies as a source of anti-infective peptides: an update 191
A peptide found in human serum, derived from the c-terminus of albumin, shows antifungal activity in vitro and in vivo 189
Antifungal properties of newly designed carbonic anhydrases inhibitors selective for microbial enzymes 189
A synthetic peptide as a novel anticryptococcal agent 184
A Naturally Occurring Antibody Fragment Neutralizes Infectivity of Diverse Infectious Agents 183
Analisi dell’attività fungicida di un peptide derivato dalla regione costante di immunoglobuline M umane 182
Screening of thiosemicarbazones as antimycotic drugs 179
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 176
AFM1 in Milk: Physical, Biological, and Prophylactic Methods to Mitigate Contamination 176
Metabolic profiling of Candida albicans 173
Antifungal peptides within the antibodies 171
An engineered anti-idiotypic antibody-derived killer peptide (KP) early activates swine inflammatory monocytes, CD3+CD16+ natural killer T cells and CD4+CD8α+ double positive CD8β+ cytotoxic T lymphocytes associated with TNF-α and IFN-γ secretion 171
Fungicidal activity of peptides encoded by immunoglobulin genes 167
Antifungal activity of the C-terminal peptide from human serum albumin 165
Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies 165
Peptides of the Constant Region of Antibodies Display Fungicidal Activity 165
Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases 163
Phenotypic modulation of porcine CD14+ monocytes, natural killer/natural killer T cells and CD8αβ+ T cell subsets by an antibody-derived killer peptide (KP) 160
Antibody constant region peptides can display immunomodulatory activity through activation of the Dectin-1 signalling pathway. 160
Cap. 6. Differenziamento reale e differenziamento temporaneo. 157
L'identificazione dei batteri Gram negativi mediante il sistema ATB. 156
Antibody peptide based antifungal immunotherapy 155
Antibodies as unlimited source of anti-infective, anti-tumor and immunomodulatory peptides 154
Peptides from the inside of the antibodies are active against infectious agents and tumours 154
Antibody Complementarity-Determining Regions (CDRs): A Bridge between Adaptive and Innate Immunity 152
Anti-septic shock recombinant vaccine. 152
Antimicrobial activity of poultry bone and meat trimmings hydrolyzates in low-sodium turkey food 151
Anticorpi immagini interne di tossine killer 150
Anticorpi antibiotici antiidiotipo immagini interne di tossine killer. 150
Natural and synthetic peptides with antifungal activity 150
Activity of an engineered synthetic killer peptide on Leishmania major and Leishmania infantum promastigotes. 149
Antibody-mediated protective immunity in fungal infections 149
Metabolic Plasticity of Candida albicans in Response to Different Environmental Conditions 149
Antibiobodies: antibiotic-like antiidiotypic antibodies. 145
Agenti virali di gastroenterite. 144
Selective miRNA down-regulation in the inhibition of HIV-1 replication by a human serum antibody-derived peptide 142
Antimicrobial peptides with antiprotozoal activity: Current state and future perspectives 141
Antibiocorpi: anticorpi antiidiotipo ad attività antibiotica e profilattica. 139
Vaccination of lactating dairy cows for the prevention of Aflatoxin B1 carry over in milk 139
Production of an engineered killer peptide in Nicotiana benthamiana by using a Potato virus X expression system 138
Anticorpi antibiotici ricombinanti ad attività terapeutica fungicida. 138
Mode of action of a killer peptide against Toxoplasma gondii 138
Antireceptor yeast killer toxin-like antibiobodies 137
Therapeutic Activity of an Anti-Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection 137
Yeast killer toxin-like candidacidal Ab6 antibodies elicited through the manipulation of the idiotypic cascade 137
Antibiobodies: antibiotic internal image antibodies 136
Dissection of the Structural Features of a Fungicidal Antibody-Derived Peptide 136
Killer peptide: a novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs 135
A killer mimotope with therapeutic activity against AIDS-related opportunistic microorganisms inhibits ex vivo HIV-1 replication 135
Anticorpi antiidiotipici ricombinanti ad attività terapeutica fungicida. 133
In vitro activity of killer peptide against Toxoplasma gondii tachyzoites 133
Metabolic profile of Candida albicans 132
Wickerhamomyces yeast killer toxins’ medical applications 132
In silico predicted antifungal peptides: In vitro and in vivo anti-candida activity 132
Attività in vitro e in vivo nei confronti di Candida albicans di peptidi sintetici progettati in silico 131
Significato diagnostico di IgA secretorie adese a cellule lievitiformi nelle candidosi orali 129
Attività terapeutica di un peptide sintetico killer nei confronti di virus influenzali 129
Antibiotic antibodies 127
In vitro and in vivo anticandidal activity of killer peptide derivatives 126
Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation 124
Therapeutic activity of a killer peptide against experimental paracoccidioidomycosis 123
Innate antimicrobial and antiviral activities of antibody peptides 123
Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins 123
Attività terapeutica di un peptide sintetico killer nei confronti di virus influenzali aviari ed umani. 122
Il sistema immunoenzimatico GM1 ELISA per la ricerca della tossina termolabile di E. coli. 122
Restriction of Influenza virus multiplication induced by PK peptide treatment 121
Development of a novel paratransgenic symbiotic-based control strategy for vector-borne infectious diseases 121
Caratterizzazione di mannoproteine da stress di Candida albicans reattive con IgA secretorie 120
Inibizione della replicazione di virus influenzali mediante trattamento di cellule infette con un peptide sintetico killer 113
Idiotypic antifungal vaccination: Immunoprotection by antiidiotypic antibiotic antibodies 113
Antibodies as Crypts of Antiinfective and Antitumor Peptides 112
Inhibition performed by a synthetic microbicidal peptide on the replication of Influenza virus. Abstract 21.009 112
Any antibody fragment might exert antifungal activity 112
Candidacidal properties of peptides encoded by immunoglobulin genes 112
Clonaggio e sequenziamento dei geni codificanti per la tossina killer di Pichia anomala 111
Applicazioni della Biologia Molecolare in Micologia. 110
L'elettroferotipo come mezzo di indagine epidemiologica nelle gastroenteriti da rotavirus umani. 110
Valutazione di un nuovo sistema automatizzato per l'identificazione e l'antibiogramma: L'identificazione rapida. Workshop: Recenti sviluppi e nuove prospettive dei metodi automatizzati per l'identificazione e l'antibiogramma. 109
Valutazione di alcuni aspetti della nuova tecnologia VITEK2 effettuata presso gli Istituti di Microbiologia dell'Università di Parma e dell'Università Cattolica di Roma. Workshop: VITEK2: un mondo d'innovazione. 109
Therapeutic potential of yeast killer toxin-like antibodies and mimotopes 108
Reversible self-assembly: A key feature for a new class of autodelivering therapeutic peptides 108
Biotyping of pathogenic fungi by the killer system and with monoclonal antibodies. 108
Antibiotic assay-based treatment of Helicobacter Pylori ( HP ) infection. 108
Relazione struttura-funzione di un peptide fungicida derivato dalla regione costante di immunoglobuline G umane 108
Caratterizzazione dell'amikacina-resistenza in Acinetobacter calcoaceticus varietà anitratus. 107
Human natural yeast killer toxin-like antibodies 107
L'automazione integrata nel Laboratorio di Batteriologia. 105
Protective antifungal yeast killer toxin-like antibodies 104
Ogni frammento anticorpale può esplicare attività antinfettiva ed antitumorale. 104
Reliability of the bacterial identification tests and of antibiotic sensitivity tests made with automatic methods. 103
Single residue contribution to self-aggregation of a fungicidal immunoglobulin-derived peptide 103
Therapeutic effect of an antibody-derived peptide in a Galleria mellonella model of systemic candidiasis 103
Totale 14.503
Salva come PNG Salva come JPEG
Categoria #
all - tutte 123.980
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 123.980
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202152 0 0 0 0 0 0 0 0 0 0 0 52
2021/20221.638 27 4 17 62 52 86 226 300 66 109 157 532
2022/20234.451 594 381 220 287 474 513 28 230 1.571 18 91 44
2023/20241.528 92 163 83 40 136 427 41 72 25 79 126 244
2024/20255.546 48 415 404 285 412 536 157 193 946 602 380 1.168
2025/202612.355 1.015 1.300 1.546 1.603 1.696 601 1.601 438 1.495 700 259 101
Totale 35.476